Investor Alert

New York Markets Close in:

Market Snapshot Winners and Losers

Protagonist Therapeutics Inc.

NAS: PTGX

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Protagonist Therapeutics Inc.

Market open

PTGX
/zigman2/quotes/205674595/composite

$

32.79

Change

+0.10 +0.31%

Volume

Volume 160,219

Dec 3, 2021, 1:29 p.m.

Real time quotes

/zigman2/quotes/205674595/composite

Previous close

$ 32.69

$ 32.79

Change

+0.10 +0.31%

Day low

Day high

$31.79

$33.17

Open
Open: 32.68

52 week low

52 week high

$12.80

$50.54

Open

Market cap

$1.56B

Average volume

1.74M

P/E ratio

N/A

Rev. per Employee

$362,380

EPS

-2.41

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/ptgx

MarketWatch News on PTGX

  1. Protagonist Therapeutics upgraded to overweight from neutral at J.P. Morgan

    5:47 a.m. Oct. 12, 2021

    - Tomi Kilgore

  3. Protagonist Therapeutics downgraded to neutral from overweight at J.P. Morgan

    5:54 a.m. Sept. 20, 2021

    - Tomi Kilgore

  4. Biotech stocks are a buy — especially these 18 picks

    1:02 p.m. March 13, 2021

    - Michael Brush

  5. Protagonist Therapeutics initiated at overweight with $35 price target at JPMorgan

    10:01 a.m. Jan. 6, 2021

    - Tonya Garcia

  6. Protagonist Therapeutics stock price target raised to $29 vs. $13 at Instinet

    7:22 a.m. May 10, 2019

    - Ciara Linnane

  7. Protagnoist Therapeutics stock price target raised to $17 from $11 at Stifel Nicolaus

    7:16 a.m. May 9, 2019

    - Tomi Kilgore

  8. Protagonist Therapeutics upgraded to buy from hold at Stifel Nicolaus

    7:16 a.m. May 9, 2019

    - Tomi Kilgore

  9. Charting the Market

    8:02 p.m. March 30, 2018

    - Barron's Online

  10. A Biotech Collapses: Is Buying Now ‘Futile’?

    4:05 p.m. March 26, 2018

    - Barrons Blogs

  12. Protagonist Therapeutics started at buy with $32 stock price target at Stifel Nicolaus

    7:22 a.m. Jan. 29, 2018

    - Tomi Kilgore

  13. Charting the Market

    9:36 p.m. June 2, 2017

    - Barron's Online

Analyst Ratings

/news/nonmarketwatch/company/us/ptgx

Other News on PTGX

  11. 10-Q: PROTAGONIST THERAPEUTICS, INC

    5:12 p.m. Nov. 3, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  13. Wall Street Breakfast: What Moved Markets

    7:47 a.m. Oct. 16, 2021

    - Seeking Alpha

  14. New Strong Sell Stocks for October 14th

    9:27 a.m. Oct. 14, 2021

    - Zacks.com

  15. CEI, ANY and HNRG among mid-day movers

    12:42 p.m. Oct. 12, 2021

    - Seeking Alpha

  17. APRN, CEI and GOTU among mid-day movers

    12:39 p.m. Oct. 11, 2021

    - Seeking Alpha

  19. CAPR, CPG and AVDL among pre market gainers

    8:21 a.m. Oct. 11, 2021

    - Seeking Alpha

  21. Loading more headlines...
/news/pressrelease/company/us/ptgx

Press Releases on PTGX

  1. Protagonist Therapeutics to Present at the JMP Securities Hematology and Oncology Summit

    7:00 a.m. Today

    - PR Newswire - PRF

  17. Protagonist Therapeutics Reports Granting of Inducement Awards

    4:05 p.m. Sept. 15, 2021

    - PR Newswire - PRF

  21. Loading more headlines...

Rates »

Mortgage Equity Savings Auto
Trending Tickers
  • /zigman2/quotes/201786389/composite USA+0.11%
  • /zigman2/quotes/205971581/composite VIXM+1.50%
  • /zigman2/quotes/204412041/composite KMX+0.98%
  • /zigman2/quotes/205782082/composite IT-0.70%
  • /zigman2/quotes/200387963/composite LINK+1.77%
X
Powered by StockTwits
Link to MarketWatch's Slice.